Article Information
History
- October 26, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC 4.0 International license.
Author Information
- Prashant Dogra1,2,
- Javier Ruiz Ramírez1,
- Joseph D. Butner1,
- Maria J. Peláez1,
- Caroline Chung3,
- Anupama Hooda-Nehra4,5,
- Renata Pasqualini4,6,
- Wadih Arap4,5,
- Vittorio Cristini1,7,8,
- George A. Calin9,
- Bulent Ozpolat10 and
- Zhihui Wang1,2,7,*
- 1Mathematics in Medicine Program, Houston Methodist Research Institute, Houston, TX 77030, USA
- 2Department of Physiology and Biophysics, Weill Cornell Medical College, New York, NY 10065, USA
- 3Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 4Rutgers Cancer Institute of New Jersey, Newark, NJ 07101, USA
- 5Department of Medicine, Division of Hematology/Oncology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA
- 6Department of Radiation Oncology, Division of Cancer Biology, Rutgers New Jersey Medical School, Newark, NJ 07103, USA
- 7Department of Imaging Physics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230, USA
- 8Physiology, Biophysics, and Systems Biology Program, Graduate School of Medical Sciences, Weill Cornell Medicine, New York, NY 10065, USA
- 9Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- 10Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
- ↵*Correspondence should be addressed to: Zhihui Wang, Ph.D.
, Associate Professor, Mathematics in Medicine Program, The Houston Methodist Research Institute, Phone: (713) 441-7291, Email: zwang{at}houstonmethodist.org
Invited Contribution
Posted October 26, 2021.
Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple Negative Breast Cancer
